Skip to main content
kovarova-TB-Study.jpg
Martina Kovarova, PhD

Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin.

Read more.